Home/ Supplements/ Lysine/ L-Lysine 1000 mg

L-Lysine 1000 mg

product on market Other (e.g. tea bag) Bluebonnet Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for L-Lysine 1000 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Caplet(s)
Serving Size
100
Servings
Amino acid/Protein
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

1000 mg
Market median: 500.0mg (159 products)

Other Ingredients

Cellulose Stearic Acid Magnesium Stearate Silicon Dioxide Vegetable Glaze
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: As a dietary supplement, take one caplet daily or as directed by a healthcare practitioner.

Warnings & Precautions

Caution: For adults only. Keep out of reach of children.

Consult physician if pregnant/nursing, taking medication, or have a medical condition.

Formulation Notes

Bluebonnet's L-Lysine 1000mg Caplets are formulated with the free-form amino acid L-lysine HCl from Ajinomoto to help support immune function and collagen synthesis.

May support Immune function Collagen synthesis

Free of milk, egg, fish, crustacean shellfish, tree nuts, peanuts, wheat, soybeans and sesame. Also free of corn, gluten, barley, rice and sugar.

Bluebonnet's KOF-K Certification #K-0000700

Made with Non GMO ingredients Gluten free

AjiPure Amino Acids

Beauty & Immune Support

V Vegan

K Parve (Kosher)

Additional Information

V Vegan K Parve (Kosher)

Store tightly closed in a cool, dry place.

Made with Non GMO ingredients

Metadata

Product Details

UPC / SKU7 43715 00057 5
DSLD Entry Date2024-08-22
Product TypeAmino acid/Protein
FormOther (e.g. tea bag)
DSLD ID316407
Data Updated2026-04-11
Research

Research Evidence

3
Research Sources
74
Avg Quality
3
Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Lysine →
Compare

Similar Products

View all Lysine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.